These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26183599)

  • 1. Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.
    Fujioka K; Sparre T; Sun LY; Krogsgaard S; Kushner RF
    J Diabetes Sci Technol; 2015 Jul; 10(1):164-74. PubMed ID: 26183599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the usability and safety of the semaglutide single-dose pen-injectors through summative (human factors) usability testing.
    Klonoff DC; Bassock S; Dwyer A; Engels E; Qvist M; Sparre T; Snitker S
    J Diabetes Investig; 2021 Jun; 12(6):978-987. PubMed ID: 33034163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing.
    Schertz JC; Saunders H; Hecker C; Lang B; Arriagada P
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1111-20. PubMed ID: 21843107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes.
    LaRue S; Malloy J
    J Diabetes Sci Technol; 2015 Jul; 9(4):815-21. PubMed ID: 25759181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration.
    Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC
    J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaglutide single-dose pen-injector: Post hoc analysis of summative usability testing for weight management.
    Klonoff DC; Bassock S; Engels E; Frederiksen M; Marber M; Qvist M; Sparre T; Snitker S
    Diabetes Obes Metab; 2021 Nov; 23(11):2590-2594. PubMed ID: 34338402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment.
    Jeannerot F; Stüdeli T; Gunther-LaVergne L; Hirning D; Schertz J
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1221-9. PubMed ID: 27329677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use.
    Mahony M; Dwyer A; Barkume R; Strochlic A; Jeannerot F; Stüdeli T
    Expert Opin Drug Deliv; 2018 Jan; 15(1):5-15. PubMed ID: 29198148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Concizumab Pen-Injector is Easy to Use and Preferred by Hemophilia Patients and Caregivers: A Usability Study Assessing Pen-Injector Handling and Preference.
    Kahr Rasmussen N; Berg B; Christiansen ASL; Neergaard JS; Ter-Borch G; Hildebrand EA; Gonczi M; Sparre T
    Patient Prefer Adherence; 2024; 18():1713-1727. PubMed ID: 39161804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
    Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
    Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LIRAGUTIDE AT A DOSE OF 3.0 MG (SAXENDA): NEW INDICATION FOR THE TREATMENT OF OBESITY].
    Scheen AJ
    Rev Med Liege; 2016 May; 71(5):256-61. PubMed ID: 27337846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
    Nadeau DA; Campos C; Niemeyer M; Bailey T
    Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure-response analyses of liraglutide 3.0 mg for weight management.
    Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
    Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
    Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
    Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study.
    Andre A; Squittieri N; Patil SB
    Adv Ther; 2021 Jun; 38(6):3129-3142. PubMed ID: 33948925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
    Matfin G; Van Brunt K; Zimmermann AG; Threlkeld R; Ignaut DA
    J Diabetes Sci Technol; 2015 Apr; 9(5):1071-9. PubMed ID: 25901022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.